In a strategic move to align with its capital structure and business objectives, Branded Legacy, Inc. reduces its authorized share count to 1.5 billion.

Melbourne, FL — November 9th, 2023 — Branded Legacy Inc., (OTC.PK: BLEG), a holdings corporation invested in biotechnical research, has officially announced a significant reduction in its authorized share count from 3 billion to 1.5 billion common shares. This decision, made by the Board of Directors, reflects the company’s commitment to aligning its capital structure with its current and anticipated business objectives.

The resolution, passed on November 8th, 2023, is seen as a strategic move to streamline the company’s share structure, making it more attractive and manageable for current and potential investors. The reduction is expected to enhance shareholder value and reflects the company’s confidence in its future growth and profitability.

“The decision to reduce our authorized share count is a clear indication of our commitment to corporate efficiency and shareholder value,” said Dave Oswald, CEO and Board Member of Branded Legacy Inc. “This move is in line with our strategic plan to optimize our capital structure and position the company for sustainable growth.”

The company has taken all necessary steps to effectuate this reduction, including filing the necessary documents with regulatory authorities, amending the company’s articles of incorporation, and updating corporate records. This change is also reflected in the company’s stock ledger.

This resolution is part of Branded Legacy Inc.’s ongoing efforts to enhance corporate governance and operational efficiency. The company remains focused on its mission to deliver innovative solutions and drive value for its stakeholders.

In ongoing commitment to enhancing shareholder value, Branded Legacy Inc. has previously announced significant strides in the company’s financial and operational strategies. Notably, the company has successfully retired 1.6 billion shares, demonstrating dedication to streamlining the share structure and bolstering investor confidence. Additionally, the recent securing of a $1M line of credit marks a pivotal step in financial planning, providing the company with the resources to fuel growth and innovation while maintaining the promise of non-dilutive financial practices. These strategic decisions reflect the continuous effort to strengthen the company’s financial foundation and position Branded Legacy for long-term success.

About Branded Legacy Inc.

Branded Legacy Inc. (OTC.PK:BLEG) is a forward-thinking holdings biotechnology company dedicated to driving innovation in plant-derived medicines and biotechnological breakthroughs. The company’s strategic partnerships and milestone achievements highlight its dedication to transforming patient care and contributing to the advancement of healthcare solutions.

Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/

 

Download this Press Release

 

Safe Harbor Statement on Forward-Looking Language: This release includes forward-looking statements, which are based on certain assumptions and reflect management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. Dilution, if any, would be for the purposes of management taking stock in lieu of cash salary. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Additionally, this press release that is not statements of historical fact may be considered to be forward-looking statements. Written words such as “may,” “will,” “expect,” “believe,” “anticipate,” “estimate,” “intends,” “goal,” “objective,” “seek,” “attempt,” or variations of these or similar words, identify forward-looking statements. By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the near future.